Unique Ingredient Identifier 3980JIH2SW is listed as a unspecified ingredient
| NCIT | C66549 | 
| RXCUI | 235496 | 
UNII 3980JIH2SW SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM is commonly included in medications in the following forms.
| Route | Dosage Form | Potency | 
|---|---|---|
| BUCCAL | FILM | 0.47 MG | 
| BUCCAL | FILM, SOLUBLE | 0.76 MG | 
| IM - IV | INJECTABLE | 0.16 % | 
| IM - IV | INJECTION | 1.47 % | 
| INTRALESIONAL | SUSPENSION, INJECTION | 0.68 % | 
| INTRAMUSCULAR | INJECTION | 2.56 % | 
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION | 0.18 %W/V | 
| INTRAMUSCULAR | SUSPENSION, EXTENDED RELEASE | 0.6 % | 
| INTRAMUSCULAR | SUSPENSION, INJECTION | 0.68 %W/V | 
| INTRASYNOVIAL | SUSPENSION, INJECTION | 0.68 % | 
| INTRAVENOUS | INJECTION | 2.56 % | 
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 0.18 % | 
| INTRAVENOUS | SOLUTION, INJECTION | 0.35 % | 
| IONTOPHORESIS | PATCH, CONTROLLED RELEASE | 14.2 MG | 
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 1.32 % | 
| OPHTHALMIC | SOLUTION | 0.19 % | 
| ORAL | SOLUTION | 25 MG/5ML | 
| ORAL | SOLUTION, LIQUID | ADJPH | 
| ORAL | SUSPENSION | 32.5 MG/5ML | 
| ORAL | TABLET | 1.38 MG | 
| SOFT TISSUE | SUSPENSION, INJECTION | 0.68 % | 
| SUBCUTANEOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.022 % | 
| SUBCUTANEOUS | SUSPENSION, INJECTION | 0.11 % | 
| TOPICAL | CREAM, AUGMENTED | 0.2 %W/W | 
| TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 0.27 %W/W | 
| TOPICAL | EMULSION, CREAM | 0.27 %W/W | 
| TOPICAL | LOTION | 0.3 %W/W | 
| TOPICAL | LOTION, AUGMENTED | 0.2 %W/W | 
| TOPICAL | PATCH, CONTROLLED RELEASE | 14.2 MG | 
| TOPICAL | SHAMPOO, SUSPENSION | NA | 
| TOPICAL | SOLUTION | 0.1 %W/V |